Odiosoft-Tinnitus — Investment Pitch
Odiosoft-Tinnitus Cover
AI-Powered Digital Therapeutics

Odiosoft-Tinnitus

AI-Powered Adaptive Notch Therapy Platform — Strategic Investment Pitch

700M+
People worldwide affected by tinnitus
Real-Time AI
Dynamic notch filtering on any audio source
SaMD Platform
Software-as-a-Medical-Device (Class IIa target)
Zero Hardware
Works on standard smartphones & headphones
Target Partner: Sonova Group & Leading MedTech InvestorsConfidential · 2025

Table of Contents

1. Executive Summary — The Vision
2. The Problem: 700 Million Unserved Patients
3. Market Opportunity (TAM · SAM · SOM)
4. Our Solution: The Living Acoustic Engine
5. Technology Platform & MVP Architecture
6. Scientific & Clinical Rationale
7. The Hybrid Sound Enrichment Advantage
8. Competitive Landscape
9. Strategic Fit with Sonova Group
10. Financial Projections & Use of Funds
Section 1

1. Executive Summary — The Vision

Odiosoft-Tinnitus is an AI-powered Software-as-a-Medical-Device (SaMD) platform designed to revolutionize tinnitus treatment. Instead of forcing patients to endure repetitive, static sound files, our platform dynamically transforms any audio source — including curated music, nature sounds, or ongoing smartphone audio — into personalized, therapeutic acoustic stimuli via Real-Time Adaptive Notch Therapy.

We are closing the gap between expensive, specialized hearing hardware and isolated, ineffective consumer apps. By turning ordinary, daily listening experiences into a continuous, clinically verified treatment layer, Odiosoft-Tinnitus democratizes evidence-based tinnitus care through standard smartphones and consumer headphones.

Key Investor Message
"We are not reinventing Notch Therapy. We are transforming it from a static and boring sound file into a living, adaptive, AI-powered digital therapeutics platform — Odiosoft-Tinnitus — that integrates seamlessly into patients' daily lives, routines, and electronic ecosystems."
Section 2

2. The Problem: 700 Million Unserved Patients

Tinnitus affects over 700 million people worldwide. A massive segment suffers from chronic, high-distress symptoms that severely impair sleep, concentration, emotional health, and workplace productivity.

Low Patient Adherence
Traditional notch therapy relies on pre-recorded static sounds (white/pink noise). Listening to a monotonous sound loop for 1–2 hours a day induces high fatigue, causing patients to abandon treatment within days.
The 'Static' Deficit
Tinnitus is a moving target. Frequencies experience frequency shift — drifting from 6000 Hz to 6200 Hz within days due to stress, fatigue, or caffeine. Static sound tracks cannot update to track these shifts, leading to therapeutic failure.
High Economic Barrier
Advanced notch therapy protocols are gatekept behind premium, thousands-of-dollars hardware solutions (e.g. high-end hearing aids), leaving the vast majority of younger and digitally native sufferers unserved.
Section 3

3. Market Opportunity (TAM · SAM · SOM)

TAM — Total Addressable Market
Global Digital Therapeutics & Hearing Health Ecosystems
SAM — Serviceable Available Market
Digital Hearing-Health Apps & Tinnitus Management (Multi-Billion USD)
SOM — Serviceable Obtainable Market
Digitally Engaged Tinnitus Patients & B2B Clinic Networks (Europe & Early Global Launch)
  • TAM: Powered by rising global smartphone adoption, an aging global demographic, and noise-induced hearing loss among younger demographics.
  • SAM: Accelerated by the expansion of consumer medical apps, remote audiology workflows, and the commercial convergence of premium audio brands into health tech.
  • SOM: Initial commercial capture maps to digitally literate tinnitus patients, private ENT networks, and premium audiology centers throughout Europe.
Section 4

4. Our Solution: The Living Acoustic Engine

Odiosoft-Tinnitus bypasses static constraints by offering an Adaptive Audio Engine that works continuously in the background. Instead of requiring dedicated "treatment hours" where a patient is isolated from the world, Odiosoft-Tinnitus applies software-driven filters to background audio seamlessly.

Patient Diagnostics
Identifies target tinnitus frequency (e.g. 4000 Hz) through precision UI matching interface.
Hybrid Sound Selection
Curated music + seamless nature loop. Two modes: Day (Music) and Night (Ocean/Rain).
Real-Time AI Notching
Micro-precision cuts applied without distortion. Q-Factor = 4–6 for surgical narrow band.
Continuous Therapy
Delivers treatment in daily background. Patients listen to content they love while receiving neurological therapy.
Section 5

5. Technology Platform & MVP Architecture

Our working Phase 1 architecture handles audio locally on smartphones to provide zero-latency, high-fidelity acoustic filtering. No cloud dependency, no privacy risk — all processing on-device.

1Frequency Matching
User matches their tinnitus frequency via precision slider (e.g. 4000 Hz or 6000 Hz)
2Audio Ingestion
Embedded license-free audio bank: ocean waves, rainfall, instrumental pieces (WAV)
3Dual-Channel Mixer
User balances music/nature ratio (e.g. 70% Music + 30% Rain Ambience)
4DSP Notch Filter
Exact notch filter slices identified frequency before routing to audio output / Bluetooth

Technical Roadmap Evolution

  • Phase 2: Integration with broader OS audio outputs (processing over streaming media like Netflix and Spotify).
  • Phase 3: Automated frequency drift tracking powered by edge AI, minimizing user manual testing over time.
Q-Factor Dynamics (The Science of Precision)

Bandwidth (Δf) = fc / Q. Using Q = 4 or Q = 6, Odiosoft-Tinnitus designs an incredibly narrow, safe valley spanning ~3700 Hz to 4300 Hz for a 4000 Hz target. This ensures structural acoustic performance while keeping audio natural and engaging to the ear.

Section 6

6. Scientific & Clinical Rationale

The Neurological Mechanism: Lateral Inhibition

Tinnitus is a phantom neurological manifestation occurring in the auditory cortex, frequently triggered by damaged hair cells failing to send appropriate signals to the brain. The brain compensates by hyper-activating those missing frequency sectors.

By engineering a precise "notch" around the patient's tinnitus frequency, Odiosoft-Tinnitus cuts all incoming energy at that target zone while intensely driving energy into the healthy neighboring frequencies. This triggers lateral inhibition: the highly active neighboring neural networks naturally suppress and quiet down the hyper-active, misfiring neurons in the center. Over time, the brain downregulates its perception of the phantom sound.

WITHOUT Odiosoft-Tinnitus
Hyper-excited auditory cortex generates phantom 4000 Hz signal. No suppression — tinnitus persists at full volume. Brain trapped in positive feedback loop.
WITH Odiosoft-Tinnitus
Adjacent frequencies [3500–3900 Hz] and [4100–4500 Hz] intensely activated. Lateral inhibition suppresses 4000 Hz phantom neurons. Tinnitus perception decreases over weeks.
Section 7

7. The Hybrid Sound Enrichment Advantage

A core scientific pillar of Odiosoft-Tinnitus is the combination of Broadband Nature Sounds and Dynamic Music Engines — clinically known as "Sound Enrichment" or Hybrid Therapy — which is significantly more effective than either alone.

Acoustic Completeness — The Broadband Power
Nature sounds (rainfall, ocean waves) operate as broadband noise, containing acoustic data across the full spectrum (20 Hz to 20,000 Hz). When notched at 4000 Hz, adjacent boundaries remain fully saturated — ensuring constant lateral inhibition with zero acoustic gaps.
Neuroplasticity Acceleration — The Music Power
Music engages the brain's limbic system (emotional center). Tinnitus is heavily correlated with anxiety and stress loops. By processing relaxing instrumental music, the brain releases dopamine and reduces autonomic stress responses — dramatically accelerating neuroplasticity and the brain's ability to rewire and ignore the phantom sound.
Patient Compliance — The Adherence Power
Patients must listen 1–2 hours daily for months for notch therapy to work. People abandon rain/wind sounds by day 3. Music is enjoyable — patients listen for months without fatigue, dramatically increasing real-world treatment adherence.

The Interactive UX Mixer

  • Daytime / Focus Mode: 80% Instrumental Music + 20% Soft Rain — keeps mind active during work while therapy runs in background.
  • Nighttime / Sleep Mode: 10% Soft Piano + 90% Deep Ocean Waves — heavy acoustic masking and comfort for sleep.
  • Custom Mode: Two sliders give patients full real-time control over their ambient blend.
Jury / Investor Defense Statement
"Rain sounds are acoustically superior for lateral inhibition, but music ensures patients stay compliant and calms the brain's stress center. Our platform dynamically delivers both based on the patient's mode — that is our clinical and commercial moat."
Section 8

8. Competitive Landscape

FeatureOdiosoft-Tinnitus ✦Hearing Aids (Signia/Widex)Mobile Masking Apps
Delivery VehiclePure Software (SaaS / SaMD)Expensive Proprietary HardwareBasic App Store Audio
PersonalizationReal-Time Dynamic AI FilteringStatic Programmable PresetsNone / Static Audio Files
Acoustic StrategyAdaptive Hybrid Sound EnrichmentBasic Tone Gen / Masking LoopsFixed White/Pink Noise Loops
Entry CostZero (Standard Headphones)High ($2,000+ USD)Low (But medically ineffective)
Frequency TrackingDynamic Shift Monitoring AIHardcoded Audiologist CalibrationNone
Section 9

9. Strategic Fit with Sonova Group

Following its landmark acquisition of Sennheiser's Consumer Division, Sonova's corporate vision relies heavily on the convergence of premium consumer audio technology and professional hearing healthcare. Odiosoft-Tinnitus is the perfect software bridge.

Sonova Hardware Ecosystem
  • Premium Sennheiser Consumer Earbuds
  • Phonak OTC & Prescription Devices
  • Global distribution & regulatory capabilities
Odiosoft-Tinnitus Software Layer
  • Scalable Digital Therapeutics (SaMD)
  • Instant Value-Add Feature Set
  • Data-driven longitudinal user connection

Strategic Value Proposition for Sonova

  • Expanding the Addressable Audience: Moves Sonova beyond traditional hearing loss demographics — opening a software service line for hundreds of millions of normal-hearing tinnitus sufferers.
  • Turnkey Consumer Integration: Odiosoft-Tinnitus integrates as companion software within Sennheiser's existing consumer apps, converting consumer TWS earbuds into clinically validated digital therapeutics.
  • Data-Driven Continuity: Provides ongoing longitudinal auditory health data, smoothly guiding users toward Sonova's premium ecosystem over time.
Section 10

10. Financial Projections & Use of Funds

5-Year Development Roadmap

Year 1
Finalize Phase 1 local MVP architecture, secure license-free audio partnerships, launch early pilot testing.
Year 2
Commercial launch of consumer subscription tiers and initial entry into key European digital health app indexes.
Year 3
Geographic expansion across European audiology networks; secure clinical and strategic validation trials.
Year 4–5
Deep API integrations with streaming platforms and consumer hardware. International multi-market scale.

Investment Ask & Capital Allocation

40%
Product Engineering & AI DSP Architecture
Moving from localized audio file rendering to system-wide ambient audio filtering capabilities.
30%
Clinical Validation & Regulatory Compliance
Running validation protocols to position as a recognized, class-compliant digital therapeutic in key EU regions.
20%
International Go-to-Market & Scale
Building relationships across audiologist networks, ENT groups, and digital patient forums.
10%
Intellectual Property Security
Hardening patents surrounding real-time adaptive notch filter routing configurations.
Odiosoft-Tinnitus | AI-Powered Adaptive Tinnitus Digital Therapeutics
Confidential Investor Presentation · Sonova Group & Leading MedTech Investors · odiosoft.tech